Cargando…

The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC

The number of patients with hepatocellular carcinoma (HCC) caused by hepatitis B virus (HBV) infection remains large, despite the remarkable effectiveness of antiviral drugs and vaccines for HBV in preventing and treating HBV infection. Necroptosis is closely related to the occurrence of inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Jianming, Zhang, Rongzheng, Xia, Yan, Jiang, Xu, Zhou, Kun, Li, Jiaqi, Guo, Mengrui, Cao, Xinyang, Zhang, Shuyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169569/ https://www.ncbi.nlm.nih.gov/pubmed/37180150 http://dx.doi.org/10.3389/fimmu.2023.1142319

Ejemplares similares

Comprehensive Analysis of m7G-Related Genes and Chronic Hepatitis B: Diagnostic Markers, Immune Microenvironment Regulation, Disease Progression
por: Zhang, Rongzheng, et al.
Publicado: (2023)

Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer
por: Xia, Yan, et al.
Publicado: (2022)

The Characteristics of Transcription Factors Regulating T Cell Exhaustion Were Analyzed to Predict the Prognosis and Therapeutic Effect in Patients with HCC
por: Li, Jingbo, et al.
Publicado: (2023)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
por: Sajid, Muhammad, et al.
Publicado: (2022)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry
por: Ke, Hengning, et al.
Publicado: (2023)

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
por: Hu, Zili, et al.
Publicado: (2022)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2013)

Increased HBV Coinfection and Decreased IFN-γ-Producing HBV-Specific CD8+ T Cell Numbers During HIV Disease Progression
por: Zhu, Zhiqiang, et al.
Publicado: (2022)

LGALS1 regulates cell adhesion to promote the progression of ovarian cancer
por: Li, Xuejian, et al.
Publicado: (2023)

Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023)

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
por: Xu, Lixia, et al.
Publicado: (2023)

Can G-quadruplex become a promising target in HBV therapy?
por: Teng, Ye, et al.
Publicado: (2022)

LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis
por: Luo, Meiyan, et al.
Publicado: (2021)

Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
por: Zhang, Chunmei, et al.
Publicado: (2022)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
por: Wang, Wenhui, et al.
Publicado: (2022)

NAFLD and HBV interplay - related mechanisms underlying liver disease progression
por: Tourkochristou, Evanthia, et al.
Publicado: (2022)

Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression
por: Ni, Lulu, et al.
Publicado: (2023)

New techniques: a roadmap for the development of HCC immunotherapy
por: Jiang, Dizhi, et al.
Publicado: (2023)

LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway
por: Xu, Debin, et al.
Publicado: (2022)

Sintilimab induced ICIAM in the treatment of advanced HCC: A case report and analysis of research progress
por: Ji, Hongxiang, et al.
Publicado: (2022)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Breaking bad: necroptosis in the pathogenesis of gastrointestinal diseases
por: Patankar, Jay V., et al.
Publicado: (2023)

Dynamics of necroptosis in kidney ischemia-reperfusion injury
por: Pefanis, Aspasia, et al.
Publicado: (2023)

Upregulation of LGALS1 is associated with oral cancer metastasis
por: Li, Ji-Min, et al.
Publicado: (2018)

Comprehensive analysis of necroptosis-related genes in renal ischemia-reperfusion injury
por: Li, Shuai, et al.
Publicado: (2023)

Knowledge Mapping of Necroptosis From 2012 to 2021: A Bibliometric Analysis
por: Zhang, Jie, et al.
Publicado: (2022)

Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC
por: Bai, Xin, et al.
Publicado: (2018)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

Tenofovir vs Entecavir Among Patients With HBV-Related HCC After Resection
por: Li, Pengpeng, et al.
Publicado: (2023)

Correction to: Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma
por: Hu, Bowen, et al.
Publicado: (2022)

Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC
por: Zhao, Zhifeng, et al.
Publicado: (2021)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC
por: Yeh, Shiou-Hwei, et al.
Publicado: (2023)

Necroptosis Contributes to Persistent Inflammation During Acute Leptospirosis
por: Kundu, Suman, et al.
Publicado: (2022)

Tumor necrosis factor is a necroptosis-associated alarmin
por: Pinci, Francesca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1v6bdvct0f2pc26t48np6dvv0v